Bajaj, PoojaMikoryak, CaroleWang, RuhungBushdiecker II, David K.Memon, PaurasDraper, Rockford K.Dieckmann, Gregg R.Pantano, PaulMusselman, Inga H.2014-07-112014-07-112014-04-162014-04-162014-02-051364-5528http://hdl.handle.net/10735.1/3670Herein, we describe a versatile immunoassay that uses biotinylated single-walled carbon nanotubes (SWNTs) as a Raman label, avidin-biotin chemistry to link targeting ligands to the label, and confocal Raman microscopy to image whole cells. Using a breast tumor cell model, we demonstrate the usefulness of the method to assess membrane receptor/ligand systems by evaluating a monoclonal antibody, Her-66, known to target the Her2 receptors that are overexpressed on these cells. We present two-dimensional Raman images of the cellular distribution of the SWNT labels corresponding to the distribution of the Her2 receptors in different focal planes through the cell with validation of the method using immunofluorescence microscopy, demonstrating that the Her-66-SWNT complexes were targeted to Her2 cell receptors.;©2014 The Royal Society of Chemistry. This article may not be further copied or distributed.Carbon nanotubesCell receptorsBreast--Cancer--ResearchA Carbon Nanotube-based Raman-imaging Immunoassay For Evaluating Tumor Targeting LigandsTextBajaj, Pooja, Carole Mikoryak, Ruhung Wang, David,K. Bushdiecker Ii, et al. 2014. "A carbon nanotube-based Raman-imaging immunoassay for evaluating tumor targeting ligands." Analyst 139 (12): 3069-3076.13912